4NOVEMBER - 2022TECH OUTLOOKIN MY OPINION14LAST WORDAnalytics as a Competitive Advantage takes 3 Things­Access, Cleanliness, and ActionMatt Southwick, Executive Director, Clinical Systems and Analytical Reporting, Amgen [NASDAQ: AMGN]30How CMOs/CDMOs can Add Value for Pharma CompaniesOzgur Akbulut, Director, Global Divestments and Contract Manufacturing Lead, Takeda [NYSE: TAK]08COV ER STORYPRECISION NANOSYSTEMSMAXIMIZING THE VALUE OF LIPID NANOPARTICLE GENOMICSLloyd Jeffs, Ph.D.,Senior Director of Biopharmaceutical Services
< Page 3 | Page 5 >